ALLO CFO sells 36,342 shares at Alpha Vantage · Investing.com South Africa · · AI-summarised by FinFlash
Allogene Therapeutics CFO Geoffrey Parker sold 36,342 shares of the company's common stock for $48,698 to cover tax withholding obligations. The sale occurred on October 21, 2026, with shares priced at Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.
Alpha Vantage · Investing.com South Africa · · AI-summarised by FinFlash
Allogene Therapeutics CFO Geoffrey Parker sold 36,342 shares of the company's common stock for $48,698 to cover tax withholding obligations. The sale occurred on October 21, 2026, with shares priced at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context